Kolorz, J.; Demir, S.; Gottschlich, A.; Beirith, I.; Ilmer, M.; Lüthy, D.; Walz, C.; Dorostkar, M.M.; Magg, T.; Hauck, F.;
et al. The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors. Curr. Oncol. 2022, 29, 94-110.
https://doi.org/10.3390/curroncol29010008
AMA Style
Kolorz J, Demir S, Gottschlich A, Beirith I, Ilmer M, Lüthy D, Walz C, Dorostkar MM, Magg T, Hauck F,
et al. The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors. Current Oncology. 2022; 29(1):94-110.
https://doi.org/10.3390/curroncol29010008
Chicago/Turabian Style
Kolorz, Julian, Salih Demir, Adrian Gottschlich, Iris Beirith, Matthias Ilmer, Daniel Lüthy, Christoph Walz, Mario M. Dorostkar, Thomas Magg, Fabian Hauck,
and et al. 2022. "The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors" Current Oncology 29, no. 1: 94-110.
https://doi.org/10.3390/curroncol29010008
APA Style
Kolorz, J., Demir, S., Gottschlich, A., Beirith, I., Ilmer, M., Lüthy, D., Walz, C., Dorostkar, M. M., Magg, T., Hauck, F., von Schweinitz, D., Kobold, S., Kappler, R., & Berger, M.
(2022). The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors. Current Oncology, 29(1), 94-110.
https://doi.org/10.3390/curroncol29010008